Patent · US Expired

Chimeric poxvirus comprising sequences of a retroviral vector component

US6352856B1 · kind B1 · utility

7Cited by

1References

15Claims

0Family size

Assignee

Baxter Vaccine AG · AT

Inventors

Falko-Guenter Falkner · Orth an der Donau, AT
Georg Holzer · Paris, FR
Friedrich Dorner · Wien, AT

Key dates

Filing date	Jan 12, 1999
Grant date	Mar 5, 2002
Priority date	—
Expiry date	Jan 12, 2019

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/13044
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A chimeric poxvirus is disclosed, which comprises the sequences of the vector component of a retroviral vector particle and optionally the packaging component of a defective retroviral particle. The chimeric poxvirus according to the invention particularly can be used for applications in gene therapy or tumor therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.